B. Riley Forecasts Celsius' Q3 Earnings (NASDAQ:CELH)

Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) - Analysts at B. Riley lifted their Q3 2025 earnings per share (EPS) estimates for Celsius in a research report issued on Wednesday, May 7th. B. Riley analyst J. Van. Sinderen now anticipates that the company will post earnings of $0.26 per share for the quarter, up from their previous estimate of $0.23. B. Riley currently has a "Buy" rating and a $49.00 target price on the stock. The consensus estimate for Celsius' current full-year earnings is $0.89 per share. B. Riley also issued estimates for Celsius' Q4 2025 earnings at $0.26 EPS, FY2025 earnings at $0.91 EPS, FY2026 earnings at $1.11 EPS and FY2027 earnings at $1.62 EPS.

Celsius (NASDAQ:CELH - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.02). The business had revenue of $329.28 million during the quarter, compared to the consensus estimate of $349.09 million. Celsius had a return on equity of 51.89% and a net margin of 10.70%. The firm's revenue for the quarter was down 7.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.27 earnings per share.

Several other research firms have also recently issued reports on CELH. Stifel Nicolaus cut their target price on Celsius from $45.00 to $37.00 and set a "buy" rating on the stock in a research note on Monday, February 10th. Needham & Company LLC reissued a "buy" rating and issued a $45.00 target price on shares of Celsius in a research note on Wednesday, May 7th. LADENBURG THALM/SH SH cut their price objective on Celsius from $62.00 to $58.00 and set a "neutral" rating on the stock in a research report on Thursday, March 27th. Piper Sandler lifted their price objective on Celsius from $43.00 to $44.00 and gave the company an "overweight" rating in a research report on Thursday, April 17th. Finally, Roth Mkm reaffirmed a "buy" rating and set a $38.00 price objective on shares of Celsius in a research report on Friday, February 21st. One research analyst has rated the stock with a sell rating, four have given a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $46.88.

Celsius Stock Performance

Shares of NASDAQ CELH traded up $0.55 during trading hours on Thursday, hitting $37.32. The company's stock had a trading volume of 6,770,928 shares, compared to its average volume of 7,876,801. The stock has a market cap of $9.62 billion, a price-to-earnings ratio of 84.82, a P/E/G ratio of 2.90 and a beta of 1.65. Celsius has a 12 month low of $21.10 and a 12 month high of $98.85. The business has a 50-day simple moving average of $34.00 and a 200-day simple moving average of $29.65.

Institutional Investors Weigh In On Celsius

Hedge funds have recently added to or reduced their stakes in the stock. HM Payson & Co. raised its stake in Celsius by 122.2% during the 4th quarter. HM Payson & Co. now owns 1,000 shares of the company's stock valued at $26,000 after buying an additional 550 shares during the last quarter. Westside Investment Management Inc. purchased a new stake in Celsius during the 1st quarter valued at $32,000. S.A. Mason LLC raised its stake in Celsius by 100.0% during the 4th quarter. S.A. Mason LLC now owns 1,400 shares of the company's stock valued at $37,000 after buying an additional 700 shares during the last quarter. MassMutual Private Wealth & Trust FSB raised its stake in Celsius by 255.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock valued at $37,000 after buying an additional 750 shares during the last quarter. Finally, GAMMA Investing LLC raised its stake in Celsius by 185.7% during the 4th quarter. GAMMA Investing LLC now owns 1,714 shares of the company's stock valued at $45,000 after buying an additional 1,114 shares during the last quarter. 60.95% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Celsius

In related news, insider Paul H. Storey sold 10,188 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $25.77, for a total value of $262,544.76. Following the transaction, the insider now directly owns 45,297 shares of the company's stock, valued at approximately $1,167,303.69. This represents a 18.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Joyce Russell sold 4,000 shares of the company's stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total value of $113,880.00. Following the completion of the transaction, the director now directly owns 19,106 shares in the company, valued at $543,947.82. This trade represents a 17.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.55% of the company's stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.